Manojit Pal

Chief Scientist

Prof. Manojit Pal
Chief Scientist

Prof. Manojit Pal received his MSc degree in Chemistry from IIT, Kharagpur, India in 1989 and Ph.D degree from Jadavpur University, Kolkata, India in 1995. During his PhD research he was trained in the area of Med Chem of N-heterocycles including uracil derivatives under the guidance of Prof. Nitya G. Kundu, an ex-member of research group of Prof Charles Heidelberger who developed the anticancer drug 5-fluorouracil. Manojit then worked as a Research Officer, R&D, Alembic Chemical Works Co Ltd. and as an Executive, Organic Synthesis, Sun Pharma Advanced Research Centre. In 1998, he joined Dr. Reddy’s Laboratories Limited (DRL) in Hyderabad as a Senior Scientist and became Senior Director Discovery Chemistry in 2006. In 2007, he joined the New Drug Discovery Department of Matrix Laboratories Limited, Hyderabad as a Senior General Manager and played the role of Administrative Head of that department. In 2009, he joined Dr. Reddy’s Institute of Life Science, Hyderabad and presently continuing as a Senior Professor of CIMPS Department. He is a recipient of the CSIR Certificate of Merit 1989, Bioorganic & Medicinal Chemistry Letters Most Cited Paper 2003-2006 Award, Bioorganic and Medicinal Chemistry Letters Top 10 Cited Author certificate for 2011-2012, Publons Peer Review Awards 2017, 2018 & 2019, Bentham Certificate of Recognition 2019 for being outstanding reviewer and others. He was recognized as one of the most cited Organic Chemists in India (Current Science 2015, 109, 869). He became Associate Editor of RSC Advances (Cambridge, UK) in 2015, FRSC in 2016, Adjunct Faculty-Manipal University in 2018 and member of Editorial Board-Bioorganic Chemistry in 2019. He also became invited member of ACS in 2019. His name is featured in Stanford’s list of top 2% scientists in the world 2020-23. In 2022, he received a certificate for publishing 10 open access articles with Elsevier between 2019–2021, four of which were linked to the United Nations Sustainable Development Goals.

His research interests include the development of new chemical entities under the new drug discovery program in various therapeutic areas namely tuberculosis, inflammation, obesity, psoriasis and cancer. So far 12 students received PhD degree under his guidance. He has authored/co-authored nearly 300 research publications, 18 review articles, a number of patents, a book chapter and a book (Elsevier). He has also edited a couple of web collections on specific topics in the area of organic synthesis including one in celebration of the 2022 Nobel Prize in Chemistry covering a decade of progress in click reactions based on CuAAC for the journal RSC Advances in 2022. Prof. Pal has long experiences in reviewing manuscripts since 2002. He has 1470 peer review records of 1251 manuscripts and 981 editor records till 2023. Ha has also reviewed PhD thesis for both national and international universities.

Full Profile